Axcelis price target raised to $100 from $90 at BofA

BofA raised the firm’s price target on Axcelis (ACLS) to $100 from $90 and keeps an Underperform rating on the shares. The firm raised targets across its semicap coverage given a stronger multi-year demand outlook, increasing visibility, greater customer diversification and the potential for higher free cash flow generation in the upturn.